136 related articles for article (PubMed ID: 33823225)
1. Perspective: sensitive detection of residual lymphoproliferative disease by NGS and clonal rearrangements-how low can you go?
Hansen MH; Cédile O; Larsen TS; Abildgaard N; Nyvold CG
Exp Hematol; 2021 Jun; 98():14-24. PubMed ID: 33823225
[TBL] [Abstract][Full Text] [Related]
2. High-throughput sequencing of T-cell receptor alpha chain clonal rearrangements at the DNA level in lymphoid malignancies.
Komkov A; Miroshnichenkova A; Nugmanov G; Popov A; Pogorelyy M; Zapletalova E; Jelinkova H; Pospisilova S; Lebedev Y; Chudakov D; Olshanskaya Y; Plevova K; Maschan M; Mamedov I
Br J Haematol; 2020 Mar; 188(5):723-731. PubMed ID: 31587259
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Sequencing Technology to Identify Minimal Residual Disease in Lymphoid Malignancies.
Kotrova M; Darzentas N; Pott C; Brüggemann M;
Methods Mol Biol; 2021; 2185():95-111. PubMed ID: 33165845
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.
Scheijen B; Meijers RWJ; Rijntjes J; van der Klift MY; Möbs M; Steinhilber J; Reigl T; van den Brand M; Kotrová M; Ritter JM; Catherwood MA; Stamatopoulos K; Brüggemann M; Davi F; Darzentas N; Pott C; Fend F; Hummel M; Langerak AW; Groenen PJTA;
Leukemia; 2019 Sep; 33(9):2227-2240. PubMed ID: 31197258
[TBL] [Abstract][Full Text] [Related]
5. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
[TBL] [Abstract][Full Text] [Related]
6. Validation of a Next-Generation Sequencing-Based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing.
Ho CC; Tung JK; Zehnder JL; Zhang BM
J Mol Diagn; 2021 Jul; 23(7):805-815. PubMed ID: 33892183
[TBL] [Abstract][Full Text] [Related]
7. Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative Disorders.
Drandi D; Ferrero S; Ladetto M
Methods Mol Biol; 2018; 1768():229-256. PubMed ID: 29717447
[TBL] [Abstract][Full Text] [Related]
8. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
[TBL] [Abstract][Full Text] [Related]
9. Is Next-Generation Sequencing the way to go for Residual Disease Monitoring in Acute Lymphoblastic Leukemia?
Kotrova M; Trka J; Kneba M; Brüggemann M
Mol Diagn Ther; 2017 Oct; 21(5):481-492. PubMed ID: 28452038
[TBL] [Abstract][Full Text] [Related]
10. Next-generation antigen receptor sequencing of paired diagnosis and relapse samples of B-cell acute lymphoblastic leukemia: Clonal evolution and implications for minimal residual disease target selection.
Theunissen PMJ; de Bie M; van Zessen D; de Haas V; Stubbs AP; van der Velden VHJ
Leuk Res; 2019 Jan; 76():98-104. PubMed ID: 30389174
[TBL] [Abstract][Full Text] [Related]
11. Detection of clonal immunoglobulin heavy-chain gene rearrangements in cases of suspected lymphoproliferative disorders: comparison of polymerase chain reaction and Southern blot analysis.
Mihalov ML; Huber S; Rachwalski E; Price JS; Hosso JM; Dizikes GJ
South Med J; 1996 Jan; 89(1):39-45. PubMed ID: 8545690
[TBL] [Abstract][Full Text] [Related]
12. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
Griesser DH
Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
[TBL] [Abstract][Full Text] [Related]
13. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
[TBL] [Abstract][Full Text] [Related]
14. Detection of clonal immunoglobulin and T-cell receptor gene recombination in hematological malignancies: monitoring minimal residual disease.
García-Castillo H; Barros-Núñez P
Cardiovasc Hematol Disord Drug Targets; 2009 Jun; 9(2):124-35. PubMed ID: 19519371
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing.
Cédile O; Hansen MH; Dahlmann SK; Kristensen TK; Abildgaard N; Nyvold CG
Exp Hematol; 2023; 119-120():14-20. PubMed ID: 36708872
[TBL] [Abstract][Full Text] [Related]
16. A comparison of deep sequencing of TCRG rearrangements vs traditional capillary electrophoresis for assessment of clonality in T-Cell lymphoproliferative disorders.
Schumacher JA; Duncavage EJ; Mosbruger TL; Szankasi PM; Kelley TW
Am J Clin Pathol; 2014 Mar; 141(3):348-59. PubMed ID: 24515762
[TBL] [Abstract][Full Text] [Related]
17. Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangements.
Sioutos N; Bagg A; Michaud GY; Irving SG; Hartmann DP; Siragy H; Oliveri DR; Locker J; Cossman J
Diagn Mol Pathol; 1995 Mar; 4(1):8-13. PubMed ID: 7735561
[TBL] [Abstract][Full Text] [Related]
18. Touch-down reverse transcriptase-PCR detection of IgV(H) rearrangement and Sybr-Green-based real-time RT-PCR quantitation of minimal residual disease in patients with chronic lymphocytic leukemia.
Peková S; Marková J; Pajer P; Dvorák M; Cetkovský P; Schwarz J
Mol Diagn; 2005; 9(1):23-34. PubMed ID: 16035732
[TBL] [Abstract][Full Text] [Related]
19. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study.
Brüggemann M; Kotrová M; Knecht H; Bartram J; Boudjogrha M; Bystry V; Fazio G; Froňková E; Giraud M; Grioni A; Hancock J; Herrmann D; Jiménez C; Krejci A; Moppett J; Reigl T; Salson M; Scheijen B; Schwarz M; Songia S; Svaton M; van Dongen JJM; Villarese P; Wakeman S; Wright G; Cazzaniga G; Davi F; García-Sanz R; Gonzalez D; Groenen PJTA; Hummel M; Macintyre EA; Stamatopoulos K; Pott C; Trka J; Darzentas N; Langerak AW;
Leukemia; 2019 Sep; 33(9):2241-2253. PubMed ID: 31243313
[TBL] [Abstract][Full Text] [Related]
20. Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma.
Yao Q; Bai Y; Orfao A; Kumar S; Chim CS
J Mol Diagn; 2020 May; 22(5):679-684. PubMed ID: 32151713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
